Helicobacter pylori-eradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach: Relationship between ulcer stage and mucosal oxidant level

Masayuki Suzuki, Hirotsugu Mihara, Hidekazu Suzuki, Tetsuji Kitahora, Shoichi Nagahashi, Tatsuhiro Masaoka, Shin Tanaka, Kouichi Suzuki, Hiromasa Ishii, Toshifumi Hibi

Research output: Contribution to journalArticle

Abstract

The level of inflammation in the gastric mucosa after the eradication of Helicobacter pylori was examined using biopsy samples obtained from patients with gastric ulcers. Gastric mucosal specimens were endoscopically obtained, before and after H. pylori-eradication therapy, from 39 patients with gastric ulcers and a positive H. pylori-infection status. The level of neutrophil-derived oxidants was then measured in each sample using a luminol-dependent chemiluminescence (ChL) assay. ChL activity in the ulcer portion and the background gastric mucosa (antrum and corpus) was significantly reduced 3 months after successful therapy (n = 32). The ChL activity was further decreased 9 months after successful therapy, but the activity in the ulcer portion remained unchanged. In patients who did not respond to the H. pylori-eradication therapy (n = 7), the ChL activities were not altered in any mucosal portion after the therapy. Before the H. pylori-eradication therapy, a higher ChL activity was observed in open ulcer tissue than in scarred tissue. The ChL activity in the scarred tissue was reduced 3 months after the successful eradication of H. pylori, however, the ChL activity in the red scars was significantly higher than that in the white scars. The ChL level in the white scars was almost equivalent to that in the background mucosa 9 months after the completion of the H. pylori-eradication therapy. In conclusion, the eradication of H. pylori may reduce the level of oxidant production in gastric ulcers, promoting the prevention of ulcer recurrence. Furthermore, the presence of a red scar may indicate unstable healing, even after the successful eradication of H. pylori.

Original languageEnglish
Pages (from-to)366-372
Number of pages7
JournalGastroenterological Endoscopy
Volume47
Issue number3
Publication statusPublished - 2005 Mar

Fingerprint

Oxidants
Helicobacter pylori
Ulcer
Luminescence
Stomach
Mucous Membrane
Neutrophils
Cicatrix
Stomach Ulcer
Therapeutics
Gastric Mucosa
Pyloric Antrum
Luminol
Helicobacter Infections
Inflammation
Biopsy
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Helicobacter pylori-eradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach : Relationship between ulcer stage and mucosal oxidant level. / Suzuki, Masayuki; Mihara, Hirotsugu; Suzuki, Hidekazu; Kitahora, Tetsuji; Nagahashi, Shoichi; Masaoka, Tatsuhiro; Tanaka, Shin; Suzuki, Kouichi; Ishii, Hiromasa; Hibi, Toshifumi.

In: Gastroenterological Endoscopy, Vol. 47, No. 3, 03.2005, p. 366-372.

Research output: Contribution to journalArticle

Suzuki, Masayuki ; Mihara, Hirotsugu ; Suzuki, Hidekazu ; Kitahora, Tetsuji ; Nagahashi, Shoichi ; Masaoka, Tatsuhiro ; Tanaka, Shin ; Suzuki, Kouichi ; Ishii, Hiromasa ; Hibi, Toshifumi. / Helicobacter pylori-eradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach : Relationship between ulcer stage and mucosal oxidant level. In: Gastroenterological Endoscopy. 2005 ; Vol. 47, No. 3. pp. 366-372.
@article{bc60f841ea9b45b191d7774088157ed8,
title = "Helicobacter pylori-eradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach: Relationship between ulcer stage and mucosal oxidant level",
abstract = "The level of inflammation in the gastric mucosa after the eradication of Helicobacter pylori was examined using biopsy samples obtained from patients with gastric ulcers. Gastric mucosal specimens were endoscopically obtained, before and after H. pylori-eradication therapy, from 39 patients with gastric ulcers and a positive H. pylori-infection status. The level of neutrophil-derived oxidants was then measured in each sample using a luminol-dependent chemiluminescence (ChL) assay. ChL activity in the ulcer portion and the background gastric mucosa (antrum and corpus) was significantly reduced 3 months after successful therapy (n = 32). The ChL activity was further decreased 9 months after successful therapy, but the activity in the ulcer portion remained unchanged. In patients who did not respond to the H. pylori-eradication therapy (n = 7), the ChL activities were not altered in any mucosal portion after the therapy. Before the H. pylori-eradication therapy, a higher ChL activity was observed in open ulcer tissue than in scarred tissue. The ChL activity in the scarred tissue was reduced 3 months after the successful eradication of H. pylori, however, the ChL activity in the red scars was significantly higher than that in the white scars. The ChL level in the white scars was almost equivalent to that in the background mucosa 9 months after the completion of the H. pylori-eradication therapy. In conclusion, the eradication of H. pylori may reduce the level of oxidant production in gastric ulcers, promoting the prevention of ulcer recurrence. Furthermore, the presence of a red scar may indicate unstable healing, even after the successful eradication of H. pylori.",
author = "Masayuki Suzuki and Hirotsugu Mihara and Hidekazu Suzuki and Tetsuji Kitahora and Shoichi Nagahashi and Tatsuhiro Masaoka and Shin Tanaka and Kouichi Suzuki and Hiromasa Ishii and Toshifumi Hibi",
year = "2005",
month = "3",
language = "English",
volume = "47",
pages = "366--372",
journal = "Gastroenterological Endoscopy",
issn = "0387-1207",
publisher = "Japan Gastroenterological Endoscopy Society",
number = "3",

}

TY - JOUR

T1 - Helicobacter pylori-eradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach

T2 - Relationship between ulcer stage and mucosal oxidant level

AU - Suzuki, Masayuki

AU - Mihara, Hirotsugu

AU - Suzuki, Hidekazu

AU - Kitahora, Tetsuji

AU - Nagahashi, Shoichi

AU - Masaoka, Tatsuhiro

AU - Tanaka, Shin

AU - Suzuki, Kouichi

AU - Ishii, Hiromasa

AU - Hibi, Toshifumi

PY - 2005/3

Y1 - 2005/3

N2 - The level of inflammation in the gastric mucosa after the eradication of Helicobacter pylori was examined using biopsy samples obtained from patients with gastric ulcers. Gastric mucosal specimens were endoscopically obtained, before and after H. pylori-eradication therapy, from 39 patients with gastric ulcers and a positive H. pylori-infection status. The level of neutrophil-derived oxidants was then measured in each sample using a luminol-dependent chemiluminescence (ChL) assay. ChL activity in the ulcer portion and the background gastric mucosa (antrum and corpus) was significantly reduced 3 months after successful therapy (n = 32). The ChL activity was further decreased 9 months after successful therapy, but the activity in the ulcer portion remained unchanged. In patients who did not respond to the H. pylori-eradication therapy (n = 7), the ChL activities were not altered in any mucosal portion after the therapy. Before the H. pylori-eradication therapy, a higher ChL activity was observed in open ulcer tissue than in scarred tissue. The ChL activity in the scarred tissue was reduced 3 months after the successful eradication of H. pylori, however, the ChL activity in the red scars was significantly higher than that in the white scars. The ChL level in the white scars was almost equivalent to that in the background mucosa 9 months after the completion of the H. pylori-eradication therapy. In conclusion, the eradication of H. pylori may reduce the level of oxidant production in gastric ulcers, promoting the prevention of ulcer recurrence. Furthermore, the presence of a red scar may indicate unstable healing, even after the successful eradication of H. pylori.

AB - The level of inflammation in the gastric mucosa after the eradication of Helicobacter pylori was examined using biopsy samples obtained from patients with gastric ulcers. Gastric mucosal specimens were endoscopically obtained, before and after H. pylori-eradication therapy, from 39 patients with gastric ulcers and a positive H. pylori-infection status. The level of neutrophil-derived oxidants was then measured in each sample using a luminol-dependent chemiluminescence (ChL) assay. ChL activity in the ulcer portion and the background gastric mucosa (antrum and corpus) was significantly reduced 3 months after successful therapy (n = 32). The ChL activity was further decreased 9 months after successful therapy, but the activity in the ulcer portion remained unchanged. In patients who did not respond to the H. pylori-eradication therapy (n = 7), the ChL activities were not altered in any mucosal portion after the therapy. Before the H. pylori-eradication therapy, a higher ChL activity was observed in open ulcer tissue than in scarred tissue. The ChL activity in the scarred tissue was reduced 3 months after the successful eradication of H. pylori, however, the ChL activity in the red scars was significantly higher than that in the white scars. The ChL level in the white scars was almost equivalent to that in the background mucosa 9 months after the completion of the H. pylori-eradication therapy. In conclusion, the eradication of H. pylori may reduce the level of oxidant production in gastric ulcers, promoting the prevention of ulcer recurrence. Furthermore, the presence of a red scar may indicate unstable healing, even after the successful eradication of H. pylori.

UR - http://www.scopus.com/inward/record.url?scp=20144386617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144386617&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:20144386617

VL - 47

SP - 366

EP - 372

JO - Gastroenterological Endoscopy

JF - Gastroenterological Endoscopy

SN - 0387-1207

IS - 3

ER -